Company · CIK 0001858685 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Biofrontera Inc. · BFRI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 MForm 4 → | Jul 29, 5:47 pm EDT | Hermann LuebbertCEO & Chairman, Director | 62,500 | — | — | 352,711 | — | |
| Jul 28, 2026 MForm 4 → | Jul 29, 5:44 pm EDT | Eugene Frederick LefflerChief Financial Officer | 31,250 | — | — | 206,250 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 MForm 4 → | Jul 29, 5:47 pm EDT | Hermann LuebbertCEO & Chairman, Director | 62,500 | — | — | 62,500 | — | |
| Jul 28, 2026 MForm 4 → | Jul 29, 5:44 pm EDT | Eugene Frederick LefflerChief Financial Officer | 31,250 | — | — | 31,250 | — |